"A shortage of human papillomavirus (HPV) vaccine in China has led thousands of women to seek treatment in neighboring countries, causing price increases and vaccine shortages, reports the Financial Times (FT).
This is important since 28% of the world’s cervical cancer patients are reported to be in China.
These Chinese women are concerned they will not be able to complete their vaccinations on schedule to prevent cervical cancer.
The Chinese market currently features Merck's original Gardasil, which protects against just 4 types of HPV, and Cervarix from GlaxoSmithKline, which protects against 2 types.
BECAUSE OF GOVERNMENT 1 CHILD POLICY, CHINESE WOMEN HAVE A HIGH ABORTION RATE.
"Human papillomavirus infection (HPV) has been identified as the cause of cervical cancer."
Determinants of cervical human papillomavirus infection:differences between high and low onocogenic risk types, PK Chang et al, J Infect Dis 185(1):28, 2002.
A survey of Hong Kong women who participated in cervical cancer screening found that the overall prevalence of HPV was 7.3%. Previous induced abortion was an 87% statistically significant increased risk for HPV for women at high risk for HPV, a 51% statistically significant increased risk for women with any HPV, and a 97% statistically significant increased risk for women with unknown risk for HPV. Other risk factors for HPV included lifetime number of sexual partners, smoking, and having smokers in the family.
"Induced Abortion in Taiwan," P.D. Dong, R.S. Lin, J. Royal Soc. Health 100-108, April, 1995
In a study of 17,047 women in Taipei, Taiwan who attended family planning services centers in 1991-1992 55% of the women had a normal Pap smear, 44% had an atypical finding and only 0.9% had dysplasia. A significantly positive trend was found between those women having had increasing numbers of induced abortions and the incidence of cervical dysplasia (P<0.01)
"Papillomavirus Infection Among Abortion Applicants and Patients at a Sexually Transmitted Disease Clinic," P.A. Csango et. al.. Sexually Transmitted Diseases 19(3): 149, May/June 1992.
A Norwegian study found that 6.1% of induced abortion applicants had human papillomavirus (HPV) infection. The proportion of high-risk HPV was 89.7%. HPV appears to be a risk factor for cervical cancer.
"Induced abortion as cancer risk factor: a review of epidemiological evidence," Larissa I. Remennick, J. Epidemiol Community Health 44(4): 259-264, Dec. 1990.
This article reviewed several studies on women in the Soviet Union and surrounding areas. It was reported that the majority of cervical cancers in Armenia were registered in three cities where induced abortion rates have been high. Where induced abortion rates have been lower in other regions, cervical cancer incidence has also been lower. Similarly, induced abortion and cervical cancer is high in migrant women, while cervical cancer and induced abortion is low in indigenous women. The author suggested that mechanisms of induced abortion influence on cervical carcinogenessis may be multiple. The first mode of action may be via general endocrine stress in the reproductive system resulting from termination of pregnancy related processes. Another is through mechanical trauma and possible infection associated with the dilation and curettage or incomplete evacuation of the embryo and placenta. Chronic inflammatory lesions may arise in cervical tissue on the site of this trauma, as well as cell abnormalities. In the course of time, the latter may undergo malignant transformation and/or facilitate the action of exogenous carcinogenic agents.
"Human Papillomaviris Infection and Other Risk Factors For Cervical Neoplasia: A Case-Control Study," E.A. Morrison, G. Ho, S.H. Vermund, G.L. Goldberg, A.S. Kadish, Int'l Journal of Cancer 49:6-13,1991.
A case-control study of inner city women in a Bronx, New York hospital during 1986-88 found that infection with human papillomaviris (HPV) was the major risk factor for cervical squamous intraepithelial lesions."
https://www.abortionrisks.org/index.php?title=Cancer_Risk_Associated_With_Abortion
view the rest of the comments →
septimasexta ago
Children’s Health Defense: The Dangers of Gardasil https://media.yellist.com/rfk-gardasil-the-science.html
septimasexta ago
28% OF CERVICAL CANCER FOUND IN CHINA
"A shortage of human papillomavirus (HPV) vaccine in China has led thousands of women to seek treatment in neighboring countries, causing price increases and vaccine shortages, reports the Financial Times (FT).
This is important since 28% of the world’s cervical cancer patients are reported to be in China.
These Chinese women are concerned they will not be able to complete their vaccinations on schedule to prevent cervical cancer.
The Chinese market currently features Merck's original Gardasil, which protects against just 4 types of HPV, and Cervarix from GlaxoSmithKline, which protects against 2 types.
It appears that during October 2017, Gardasil 9 became ‘temporarily on limited supply.’ Merck, Gardasil’s manufacturer, said they ‘expect this vaccine shortage to continue through July 2018.’ " https://www.precisionvaccinations.com/merck-gardasil-9-hpv-vaccine-not-listed-cdc-‘delay-or-shortage
BECAUSE OF GOVERNMENT 1 CHILD POLICY, CHINESE WOMEN HAVE A HIGH ABORTION RATE.
"Human papillomavirus infection (HPV) has been identified as the cause of cervical cancer."
Determinants of cervical human papillomavirus infection:differences between high and low onocogenic risk types, PK Chang et al, J Infect Dis 185(1):28, 2002. A survey of Hong Kong women who participated in cervical cancer screening found that the overall prevalence of HPV was 7.3%. Previous induced abortion was an 87% statistically significant increased risk for HPV for women at high risk for HPV, a 51% statistically significant increased risk for women with any HPV, and a 97% statistically significant increased risk for women with unknown risk for HPV. Other risk factors for HPV included lifetime number of sexual partners, smoking, and having smokers in the family.
"Induced Abortion in Taiwan," P.D. Dong, R.S. Lin, J. Royal Soc. Health 100-108, April, 1995 In a study of 17,047 women in Taipei, Taiwan who attended family planning services centers in 1991-1992 55% of the women had a normal Pap smear, 44% had an atypical finding and only 0.9% had dysplasia. A significantly positive trend was found between those women having had increasing numbers of induced abortions and the incidence of cervical dysplasia (P<0.01)
"Papillomavirus Infection Among Abortion Applicants and Patients at a Sexually Transmitted Disease Clinic," P.A. Csango et. al.. Sexually Transmitted Diseases 19(3): 149, May/June 1992. A Norwegian study found that 6.1% of induced abortion applicants had human papillomavirus (HPV) infection. The proportion of high-risk HPV was 89.7%. HPV appears to be a risk factor for cervical cancer.
"Induced abortion as cancer risk factor: a review of epidemiological evidence," Larissa I. Remennick, J. Epidemiol Community Health 44(4): 259-264, Dec. 1990. This article reviewed several studies on women in the Soviet Union and surrounding areas. It was reported that the majority of cervical cancers in Armenia were registered in three cities where induced abortion rates have been high. Where induced abortion rates have been lower in other regions, cervical cancer incidence has also been lower. Similarly, induced abortion and cervical cancer is high in migrant women, while cervical cancer and induced abortion is low in indigenous women. The author suggested that mechanisms of induced abortion influence on cervical carcinogenessis may be multiple. The first mode of action may be via general endocrine stress in the reproductive system resulting from termination of pregnancy related processes. Another is through mechanical trauma and possible infection associated with the dilation and curettage or incomplete evacuation of the embryo and placenta. Chronic inflammatory lesions may arise in cervical tissue on the site of this trauma, as well as cell abnormalities. In the course of time, the latter may undergo malignant transformation and/or facilitate the action of exogenous carcinogenic agents.
"Human Papillomaviris Infection and Other Risk Factors For Cervical Neoplasia: A Case-Control Study," E.A. Morrison, G. Ho, S.H. Vermund, G.L. Goldberg, A.S. Kadish, Int'l Journal of Cancer 49:6-13,1991. A case-control study of inner city women in a Bronx, New York hospital during 1986-88 found that infection with human papillomaviris (HPV) was the major risk factor for cervical squamous intraepithelial lesions." https://www.abortionrisks.org/index.php?title=Cancer_Risk_Associated_With_Abortion